OpenAI· @OpenAI · X·· 27 天前AI 评分61
AI 导读
OpenAI 宣布收购 Orchestra Bio,后者是帮助生物制药团队协调药物研发流程的平台。OpenAI 表示将基于其生命科学研究的 AI 模型与工具 Rosalind 继续建设,以简化这些运营流程,让新疗法更快到达患者。
正文 · 原文
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.
Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.
Welcome @ashokaraj_ and team!
来源:OpenAI · x.com